76-825

Tocris Bioscience™ JQAD1

Manufacturer: Tocris Bioscience™

CAS Number: 2417097-18-6

Select a Size

Pack Size SKU Availability Price
Each of 1 76-825-Each-of-1 In Stock ₹ 48,505.00

76-825 - Each of 1

₹ 48,505.00

In Stock

Quantity

1

Base Price: ₹ 48,505.00

GST (18%): ₹ 8,730.90

Total Price: ₹ 57,235.90

Chemical Name or Material

12-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)-N-((R)-3 '-(2-((4-fluorobenzyl)(-1,1,1-trifluoropropan-2-yl)amino)-2-oxoethyl)-2 ',4 '-dioxo-2,3-dihydrospiro[indene-1,5 '-oxazolidin]-5-yl)dodecanamide

Quantity

5 mg

Molecular Formula

C48H52F4N6O9

CAS

2417097-18-6

Target

Active Degraders

Purity

98%

Related Products

Img

Tocris Bioscience™

75-885

--

Img

Tocris Bioscience™

72-401

--

Img

Tocris Bioscience™

75-835

--

Img

Tocris Bioscience™

69-715

--

Img

Tocris Bioscience™

73-965

--

Img

Tocris Bioscience™

75-045

--

Img

Tocris Bioscience™

75-305

--

Img

Tocris Bioscience™

73-975

--

Description

  • JQAD1 is a potent and selective histone acetyltransferase EP300 degrader (PROTAC™; DC50 ≤ 31.6 nM); comprises an EP300 inhibitor, A485 (Cat.No
  • 6387), joined by a linker to a cereblon E3 ligase ligand
  • JQAD1 brings about degradation of EP300 in neuroblastoma cell lines in a proteasome-dependent manner
  • JQAD1 suppresses both H3K27ac and EP300 expression levels and induces apoptosis
  • JQAD1 suppresses tumors growth in NSG mice xenografted with Kelly cells
  • CRC and MYCN genes are downregulated in tumors treated with JQAD1
  • JQAD1 exhibits no significant effect on coactivator CBP at concentrations inducing EP300 degradation
  • PROTAC™ is a registered trademark of Arvinas Operations, Inc., and is used under license.

SAFETY INFORMATION

  • Recommended Storage : Store at -20°C